Skip to main content
. 2021 Apr 6;8:659188. doi: 10.3389/fmed.2021.659188

Table 2.

The genotype and allele distributions of studied polymorphisms between controls and cases.

SNPs Genotype/allele Controls Cases χ2 P*
ApoB gene
rs1042034 CC 373 (57.12%) 319 (55.48%) 18.11 <0.001
CT 270 (41.35%) 221 (38.43%)
TT 10 (1.53%) 35 (6.09%)
T 290 (22.21%) 291 (25.30%) 3.25 0.071
rs679899 AA 453 (69.37%) 409 (71.13%) 3.27 0.195
AG 188 (28.79%) 148 (25.74%)
GG 12 (1.84%) 18 (3.13%)
G 212 (16.23%) 172 (15.11%) 0.57 0.448
rs1367117 GG 496 (75.96%) 434 (75.48%) 0.04 0.981
AG 147 (22.51%) 132 (22.96%)
AA 10 (1.53%) 9 (1.57%)
A 167 (12.79%) 150 (13.04%) 0.04 0.850
rs12720838 CC 455 (69.68%) 393 (68.35%) 9.70 0.008
CT 192 (29.4%) 162 (28.17%)
TT 6 (0.92%) 20 (3.48%)
T 204 (15.62%) 202 (17.57%) 1.68 0.195
PCSK9 gene
rs662145 TT 505 (77.34%) 434 (75.48%) 1.34 0.511
CT 137 (20.98%) 134 (23.30%)
CC 11 (1.68%) 7 (1.22%)
C 159 (12.17%) 148 (12.87%) 0.27 0.603
rs45448095 CC 544 (83.31%) 454 (78.96%) 3.84 0.147
CT 103 (15.77%) 115 (20.00%)
TT 6 (0.92%) 6 (1.04%)
T 115 (8.81%) 127 (11.04%) 3.45 0.063

SNPs, single nucleotide polymorphisms.

*

P was calculated using the χ2-test.